Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis.

Zafar SN, Khan AA, Ghauri AA, Shamim MS.

BMC Neurol. 2012 May 29;12:30. doi: 10.1186/1471-2377-12-30. Review.

2.

Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.

Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA.

Neurocrit Care. 2010 Apr;12(2):165-72. doi: 10.1007/s12028-009-9304-y.

PMID:
19898966
3.

A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis.

Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, Scalea TM, Dubose J, Demetriades D.

J Trauma Acute Care Surg. 2013 Mar;74(3):766-71; discussion 771-3. doi: 10.1097/TA.0b013e3182826e84.

PMID:
23425733
4.

Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.

Gabriel WM, Rowe AS.

Ann Pharmacother. 2014 Nov;48(11):1440-4. doi: 10.1177/1060028014549013. Epub 2014 Aug 28.

PMID:
25169249
5.

Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.

Kruer RM, Harris LH, Goodwin H, Kornbluth J, Thomas KP, Slater LA, Haut ER.

J Crit Care. 2013 Oct;28(5):883.e9-13. doi: 10.1016/j.jcrc.2012.11.020. Epub 2013 Apr 6.

PMID:
23566730
6.

A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.

Pieracci FM, Moore EE, Beauchamp K, Tebockhorst S, Barnett CC, Bensard DD, Burlew CC, Biffl WL, Stoval RT, Johnson JL.

J Trauma Acute Care Surg. 2012 Jan;72(1):276-81. doi: 10.1097/TA.0b013e31823df31f.

PMID:
22310136
7.

Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.

Bansal S, Blalock D, Kebede T, Dean NP, Carpenter JL.

J Neurosurg Pediatr. 2014 Feb;13(2):209-15. doi: 10.3171/2013.10.PEDS13256. Epub 2013 Nov 29.

PMID:
24286154
8.

Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.

Cotton BA, Kao LS, Kozar R, Holcomb JB.

J Trauma. 2011 Aug;71(2):375-9. doi: 10.1097/TA.0b013e318224d307.

PMID:
21825941
9.

Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.

Iuchi T, Kuwabara K, Matsumoto M, Kawasaki K, Hasegawa Y, Sakaida T.

J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1158-62. doi: 10.1136/jnnp-2014-308584. Epub 2014 Dec 15.

PMID:
25511789
10.

Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.

Fuller KL, Wang YY, Cook MJ, Murphy MA, D'Souza WJ.

Epilepsia. 2013 Jan;54(1):45-57. doi: 10.1111/j.1528-1167.2012.03563.x. Epub 2012 Jun 27.

11.

A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.

Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, McCutcheon IE, Prabhu SS, Heimberger AB, Sawaya R, Wang X, Qiao W, Hess KR, Lang FF.

J Neurosurg. 2013 Apr;118(4):873-83. doi: 10.3171/2012.12.JNS111970. Epub 2013 Feb 8.

12.

Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy.

Kern K, Schebesch KM, Schlaier J, Hansen E, Feigl GC, Brawanski AT, Lange M.

J Clin Neurosci. 2012 Jan;19(1):99-100. doi: 10.1016/j.jocn.2011.07.021. Epub 2011 Nov 30.

PMID:
22133815
13.

Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.

Karamchandani RR, Fletcher JJ, Pandey AS, Rajajee V.

J Clin Neurosci. 2014 Sep;21(9):1507-13. doi: 10.1016/j.jocn.2014.03.009. Epub 2014 Jun 3.

14.

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS.

Mayo Clin Proc. 2004 Dec;79(12):1489-94.

PMID:
15595331
15.

Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.

Taylor S, Heinrichs RJ, Janzen JM, Ehtisham A.

Neurocrit Care. 2011 Aug;15(1):80-4. doi: 10.1007/s12028-010-9341-6.

PMID:
20890680
16.

Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.

Steinbaugh LA, Lindsell CJ, Shutter LA, Szaflarski JP.

Epilepsy Behav. 2012 Mar;23(3):280-4. doi: 10.1016/j.yebeh.2011.12.005. Epub 2012 Feb 16.

PMID:
22342434
17.

Antiepileptic drugs for treating seizures in adults with brain tumours.

Kerrigan S, Grant R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008586. doi: 10.1002/14651858.CD008586.pub2. Review.

PMID:
21833969
18.

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW.

J Neurooncol. 2009 Jul;93(3):349-54. doi: 10.1007/s11060-008-9781-4. Epub 2009 Jan 24.

19.

Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.

Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, Stippler M, Fischer M, Sauber-Schatz EK, Fabio A, Darby JM, Okonkwo DO.

Neurosurg Focus. 2008 Oct;25(4):E3. doi: 10.3171/FOC.2008.25.10.E3.

20.

A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.

Garbossa D, Panciani PP, Angeleri R, Battaglia L, Tartara F, Ajello M, Agnoletti A, Versari P, Ducati A, Fontanella M, Spena G.

Neurol India. 2013 Mar-Apr;61(2):131-7. doi: 10.4103/0028-3886.111118.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk